Adverse events associated with Covishield vaccination among healthcare workers in a tertiary hospital in South India

被引:5
|
作者
Sathyapalan, Dipu T. [1 ]
Moni, Merlin [1 ]
Prasanna, Preetha [2 ]
Marwaha, Vishal [3 ]
Madathil, Sai Bala [2 ]
Edathadathil, Fabia [4 ]
Jose, Sony A. [5 ]
Pavithran, Sheela [6 ]
Muralikrishanan, Rajasree [7 ]
Ramachandran, Nigith [7 ]
Roshni, P. R. [8 ]
Tinu, T. S. [9 ]
Nair, Anjana S. [2 ]
Kuriachan, Sanitha [10 ]
Palatty, Princy Louis [10 ]
机构
[1] Amrita Vishwa Vidyapeetham, Dept Gen Med, Div Infect Dis, Amrita Inst Med Sci, Kochi, Kerala, India
[2] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Kochi, Kerala, India
[3] Amrita Vishwa Vidyapeetham, Dept Rheumatol, Amrita Inst Med Sci, Kochi, Kerala, India
[4] Amrita Vishwa Vidyapeetham, Dept Infect Control & Epidemiol, Amrita Inst Med Sci, Kochi, Kerala, India
[5] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Dept Nursing, Amrita Coll Nursing, Kochi, Kerala, India
[6] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Amrita Coll Nursing, Kochi, Kerala, India
[7] Amrita Vishwa Vidyapeetham, Dept Community Med, Amrita Inst Med Sci, Kochi, Kerala, India
[8] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, Dept Pharm Practice, Amrita Sch Pharm, Kochi, Kerala, India
[9] Amrita Vishwa Vidyapeetham, Amrita Inst Med Sci, ADR Monitoring Ctr, Kochi, Kerala, India
[10] Amrita Vishwa Vidyapeetham, Dept Pharmacol, Amrita Inst Med Sci, AIMS PO, Kochi 682041, Kerala, India
来源
VACCINE: X | 2022年 / 12卷
关键词
D O I
10.1016/j.jvacx.2022.100210
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Vaccination is the most important prophylactic measure taken to curb COVID-19 pandemics. This study was undertaken to throw light on the safety of Covishield vaccine among health care workers (HCWs) and to assess the co-variates associated with incidence of adverse events. Methods: This prospective observational study was conducted in a tertiary care center in South India as part of the HCW vaccination drive. All consenting HCWs who received the first dose of Covishield vaccine and developed ADRs were included in this study. After vaccination, all beneficiaries were monitored for AEFI for a period of half an hour and later followed up through telephone and google survey forms on day 2 and day 7 of vaccination. The data was subsequently collated into spreadsheet format and analyzed. Results: The study included 1264 consenting healthcare workers who were predominantly youth, aged 15-24 years (n = 583, 46 %) and with a female preponderance of 76 % (n = 960). Past history of COVID-19 infections was reported among 4.6 % (58) of the study population. Postvaccination symptoms were majorly reported during the first (40 %) and second day (44 %) after vaccination with a high prevalence of both local (n = 1083, 85 %) and systemic symptoms (n = 1065, 84 %). The mean duration of symptoms was observed to be 1.4 +/- 0.81 days post vaccination. Symptoms were observed significantly high among females (76.7 %, p = 0.013). The prevalence of systemic (88 % vs 80 %) (p < 0.001) and allergic symptoms (7 % vs 3 %; p = 0.03) were observed to be significantly high among respondents with < 25 years of age. The systemic and allergic symptoms following vaccination were reported to be low among health-care workers who had a previous history of COVID-19 infection. Conclusion: COVID vaccination has been observed to be safe and well tolerated with more systemic symptoms reported among younger age group and females. (C) 2022 The Authors. Published by Elsevier Ltd.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Adverse events associated with Measles and Rubella vaccination campaign 2019 in India
    Sharma, Roop
    Gaur, Ajay
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2021, 10 (01) : 44 - 46
  • [42] Surveillance on Adverse Events Following COVISHIELD (ChAdOx1 nCoV-19) vaccination in Goa, India: An Observational Study
    Jose, Dhanya
    Dhupdale, Nitin
    Cacodcar, Jagadish A.
    Kamat, Umesh
    CURRENT DRUG SAFETY, 2023, 18 (04) : 516 - 527
  • [43] The Impact of Personal Protective Equipment on Healthcare Workers on COVID-19 Duty in a Tertiary Care Hospital in South India
    Haward, Raymond
    Ridhima, G.
    Kalyan, Meenakshi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (07)
  • [44] Profile of Serious Adverse Drug Events in a Tertiary Care Hospital of South India-a Five Years Example Abstracts
    Pasha, M. Y.
    Muraraiah, S.
    Jayanthi, C. R.
    DRUG SAFETY, 2016, 39 (10) : 992 - 992
  • [45] Prevalence of adverse drug reactions at a private tertiary care hospital in south India
    Sriram, Shanmugam
    Ghasemi, Ali
    Ramasamy, Rajeswari
    Devi, Manjula
    Balasubramanian, Rajalingam
    Ravi, Thengungal Kochupapy
    Sabzghabaee, Ali Mohammad
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (01): : 16 - 25
  • [46] Needlestick injury among healthcare workers of a tertiary care centre in Haryana, India
    Pathak, Rambha
    Ahluwalia, S. K.
    Pathania, Deepak
    Chaudhary, Chintu
    Chahar, Saagar
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (10): : 563 - 564
  • [47] Hepatitis B Seropositivity and Vaccination Coverage among Health Care Workers in a Tertiary Care Hospital in Moradabad, UP, India
    Kumar, Sumit
    Begum, Rehana
    Farooq, Umar
    Kumari, Pallavi
    INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY, 2014, 1 (04) : 43 - 46
  • [48] Influenza vaccination among healthcare workers
    Habib, S
    Rishpon, S
    Rubin, L
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2000, 2 (12): : 899 - 901
  • [49] Hand hygiene practice compliance among healthcare workers in a tertiary healthcare hospital in Kathmandu, Nepal
    Duwal, Sarita
    Budhathoki, Lee
    Dhaubanjar, Manisha
    Rijal, Durga
    Acharya, Puspa
    PLOS GLOBAL PUBLIC HEALTH, 2024, 4 (08):
  • [50] A STUDY ON ADVERSE DRUG REACTION RELATED HOSPITAL ADMISSIONS OF A TERTIARY CARE HOSPITAL IN SOUTH INDIA
    Kuruvilla, A.
    VALUE IN HEALTH, 2021, 24 : S92 - S92